Home Industries Reports Services About Us Publisher Contact us

Global Hereditary Angioedema Therapeutic Market - By Type (Intravenous, Subcutaneous, Oral), By Application (Hospitals, Clinics, Others) - Trends and Forecast to 2030

Type: PDF

Status: Syndicate

Categories: Biotechnology

Report Code : BT23

No. of Pages : 150

Hereditary angioedema is a drug class of genetic disorder characterized from number of recurring episodes of swelling referred as angioedema. These swells occur in few areas of the body such as the limbs, intestinal tract, airway and face. Usually, stress to minor trauma can trigger an attack, but swelling of the limbs can occur without known triggers. The swelling in the airway is specifically dangerous considering it can obstruct the host’s breathing resulting in life-threatening obstruction.

The global hereditary angioedema therapeutic market in 2023 was approximately USD 3.2 Billion. The market is expected to grow at a CAGR of 14.7% and is anticipated to reach around USD 3.6 Billion by 2030. The key reason for the projection of boosting the hereditary angioedema therapeutic market growth during the forecast period is rise in occurrences of hereditary angioedema coupled with the various innovative methods to treat this disorder.

The market for hereditary angioedema therapeutic is intensely competitive and is highly fragmented. The vendors in the hereditary angioedema therapeutic market compete based on product portfolio, product differentiation, applications, and the pricing of products.

The rise in technological innovations in designing the products for better quality, ease of use and better performance is expected to continue to intensify the level of competition among the companies to expand their product portfolios by incorporating innovative features, into their product. Key players in the market are BioCryst Pharma, Ionis Pharma, Pharming Group, CSL Limited, Shire, Attune Pharma, Adverum Biotechnologies, KalVista Pharma and Others.

Request For List of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Table of Contents

  1. Introduction
    • Key Insights
    • Report Overview
    • Markets Covered
    • Stakeholders

 

  1. Research Methodology
    • Research Scope
    • Market Research Process
    • Research Data Analysis
      • Secondary Research
      • Primary Research
      • Models for Estimation
    • Market Size Estimation
      • Bottom-Up Approach - Segmental Market Analysis
      • Top-Down Approach - Parent Market Analysis             
  1. Executive Summary             
  2. Market Overview
    • Introduction
      • Drivers
      • Restraints
      • Opportunities
      • Challenges
    • Porter's Five Force Analysis                             
  3. Global Hereditary Angioedema Therapeutic Market, By Type
    • Introduction
    • Intravenous
      • Market Overview
      • Market Size and Forecast
    • Subcutaneous
      • Market Overview
      • Market Size and Forecast
    • Oral
      • Market Overview
      • Market Size and Forecast

                                                                                               

  1. Global Hereditary Angioedema Therapeutic Market, By Application
    • Introduction
    • Hospitals
      • Market Overview
      • Market Size and Forecast
    • Clinics
      • Market Overview
      • Market Size and Forecast
    • Others
      • Market Overview
      • Market Size and Forecast                                                                                             
  1. Global Hereditary Angioedema Therapeutic Market, By Geography
    • Introduction
    • North America
      • North America Global Hereditary Angioedema Therapeutic Market, By Type
      • North America Global Hereditary Angioedema Therapeutic Market, By Applications
    • Europe
      • Europe Global Hereditary Angioedema Therapeutic Market, By Type
      • Europe Global Hereditary Angioedema Therapeutic Market, By Applications
    • Asia-Pacific
      • Asia-Pacific Global Hereditary Angioedema Therapeutic Market, By Type
      • Asia-Pacific Global Hereditary Angioedema Therapeutic Market, By Applications
    • Rest of the World
      • Rest of the World Global Hereditary Angioedema Therapeutic Market, By Type
      • Rest of the World Global Hereditary Angioedema Therapeutic Market, By Applications                                           
  1. Competitive Insights
    • Key Insights
    • Company Market Share Analysis
    • Strategic Outlook
      • Mergers & Acquisitions
      • New Product Development
      • Portfolio/Production Capacity Expansions
      • Joint Ventures, Collaborations, Partnerships & Agreements
      • Others                                 
  1. Company Profiles
    • BioCryst Pharma
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Ionis Pharma
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Pharming Group
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • CSL Limited
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Shire
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Attune Pharma
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Adverum Biotechnologies
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • KalVista Pharma
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Others
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments

Request For Research Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Global United Research

Report Code

BT23

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Related Reports

Global Hereditary Angioedema Therapeutic Market - ...

RD Code : BT23